- Advocacy in Action: Drug pricing discussions continue, HHS delays “conscience” rule implementation, and Dr. Collins shares a special Fourth of July blog post.
- Heavy Player One: How Screen Time and Snacking Impacts Adolescent Obesity
- Remembering Elizabeth Barrett-Connor, MD, 1935—2019
- The Long Haul: Treating Men with Obesity with Testosterone
Less than three weeks remain until the early registration deadline for Clinical Endocrinology Update (CEU) and Endocrine Board Review (EBR). Register for these meetings today to take advantage of our best pricing. After August 1, you will still be able to register, but at a higher rate.
To accommodate your schedule and location, CEU is being offered in two locations:
Join hundreds of your colleagues from around the world to discover the latest updates in clinical endocrinology from renowned experts.
EBR is coming to Seattle, Washington, September 17-18, and is the premier case-based course and mock exam in the field, allowing you to test your knowledge in everyday practice.
Further your clinical education and earn CME and MOC credits today! Our free online educational activities are available on-demand, offering you the flexibility of continuing your education on-the-go.
Our course titled "Endocrine Treatment of Gender-Dysphoric/Gender Incongruent Persons: An Endocrine Society Clinical Practice Guideline Educational Activity" expires September 15, 2019. Take this free course today!
Take action to help us support endocrinology research, care, professionals, and patients through our advocacy campaigns. Make your voice heard!
Take action now.
Impact the health and well-being of communities through EndoCares, an outreach program that provides medical resources, coaching, and education to local providers and patients suffering from endocrine-related conditions in under served areas of the world.
Make a difference today.
Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic ReviewTreatment
Although diagnosis and management of functional and neoplastic long-term consequences of cancer therapy are comparable to other causes of endocrine disorders, cancer survivors need individually structured follow-up care in specialized surveillance centers to improve care for this rapidly growing group of patients.
In the last few years, a series of articles has unveiled a previous unknown relation of these kinases with metabolic regulation and the homeostasis of metabolic tissues. The aim of this review is to bring together this body of data to provide a detailed picture of the current knowledge about these proteins, metabolism, and some of the associated diseases.
Treatment of Central Precocious Puberty
In this review, important issues pertaining to the treatment of children with CPP are discussed.
Although survivors had lower levels of AMH and AFC at the time of enrollment, the rate of change of AMH and AFC is not significantly different than similar-aged controls.